Inventor · disambiguated record
Kunyuan Cui
Also filed as: CUI KUNYUAN
8 granted patents·25 pending applications·15 citations·filing 2004–2023
80Inventor score
Files withNASTECH PHARM CO16KYLONOVA XIAMEN BIOPHARMA CO LTD4CHEN LISHAN2CUI KUNYUAN2MARINA BIOTECH INC2
Top patents by PatentIndex Score
33 records- 0181US9233971B2Lipomacrocycles and uses thereofCUI KUNYUAN·Filed 2011·Granted Jan 12, 2016·5 cites·50 claims
- 0278US9080186B2Compositions comprising cationic amphiphiles and colipids for delivering therapeutic moleculesCUI KUNYUAN·Filed 2010·Granted Jul 14, 2015·6 cites·22 claims
- 0374US7696343B2Method for opening tight junctionsMDRNA INC·Filed 2007·Granted Apr 13, 2010·1 cites·6 claims
- 0469US8299236B2Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cellsCHEN LISHAN·Filed 2008·Granted Oct 30, 2012·3 cites·13 claims
- 0569US2007155658A1Nanoparticles for delivery of nucleic acids and stable double-stranded rnaNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 0668US2009274658A1Tight Junction Modulating Peptides for Enhanced Mucosal Delivery of Therapeutic CompoundsNASTECH PHARM CO·Filed 2009·Application pending·0 cites
- 0765US2015252369A1Methods and compositions for enhancing delivery of double-stranded rna or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cellsMARINA BIOTECH INC·Filed 2014·Application pending·0 cites
- 0865US2005136437A1Nanoparticles for delivery of nucleic acids and stable double-stranded RNANASTECH PHARM CO·Filed 2004·Application pending·0 cites
- 0964US2006122137A15'-methylpyrimidine and 2'-O-methyl ribonucleotide modified double-stranded ribonucleic acid moleculesNASTECH PHARM CO·Filed 2005·Application pending·0 cites
- 1063US2008261304A1Methods and compositions for enhancing delivery of double-stranded rna or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cellsNASTECH PHARM CO·Filed 2008·Application pending·0 cites
- 1161US2007154449A1Tight junction modulating peptides for enhanced mucosal delivery of therapeutic compoundsNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 1260US2005129679A1Method for opening tight junctionsNASTECH PHARM CO·Filed 2004·Application pending·0 cites
- 1359US2025066789A1AGT Inhibitor and Use ThereofKYLONOVA XIAMEN BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1458US2025277211A1LPA inhibitors and uses thereofKYLONOVA XIAMEN BIOPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 1557US2010022618A1Long interfering nucleic acid duplexes targeting multiple RNA targetsLIANG DONG·Filed 2008·Application pending·0 cites
- 1656US2007293449A1Compositions and methods for delivery of double-stranded rnaNASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 1755US11690818B2Drug containing liver targeting specific ligand and thyroid hormone receptor agonistKYLONOVA XIAMEN BIOPHARMA CO LTD·Filed 2019·Granted Jul 4, 2023·0 cites·4 claims
- 1855US2006014289A1Methods and compositions for enhancing delivery of double-stranded RNA or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cellsNASTECH PHARM CO·Filed 2005·Application pending·0 cites
- 1955US2010247482A1Tight junction modulator peptides for enhanced mucosal delivery of therapeutic compoundsNASTECH PHARM CO·Filed 2008·Application pending·0 cites
- 2055US2004253211A1Method for diagnosing and treating cancerNASTECH PHARM CO·Filed 2004·Application pending·0 cites
- 2153US8940857B2Methods and compositions for enhancing delivery of double-stranded RNA or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cellsAHMADIAN MOHAMMAD·Filed 2010·Granted Jan 27, 2015·0 cites·9 claims
- 2252US11623938B2Liver-targeting compound having thyroid hormone receptor agonist characteristics and pharmaceutical composition thereofKYLONOVA XIAMEN BIOPHARMA CO LTD·Filed 2020·Granted Apr 11, 2023·0 cites·13 claims
- 2352US9777278B2Long interfering nucleic acid duplexes targeting multiple RNA targetsBIOMICS BIOTECHNOLOGIES CO LTD·Filed 2015·Granted Oct 3, 2017·0 cites·23 claims
- 2452US2016206749A1Methods and compositions for enhancing delivery of double-stranded rna or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cellsMARINA BIOTECH INC·Filed 2015·Application pending·0 cites
- 2551US2009018097A1Modification of double-stranded ribonucleic acid moleculesMDRNA INC·Filed 2006·Application pending·0 cites
- 2650US2010129460A1Compounds and methods for peptide ribonucleic acid condensate particles for rna therapeuticsNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 2750US2010113332A1Method of treating an inflammatory disease by double stranded ribonucleic acidNASTECH PHARM CO·Filed 2005·Application pending·0 cites
- 2848US2007281900A1COMPOSITIONS AND METHODS FOR LIPID AND POLYPEPTIDE BASED siRNA INTRACELLULAR DELIVERYNASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 2947US2006062758A1Tight junction modulator peptide PN159 for enhanced mucosal delivery of therapeutic compoundsNASTECH PHARMACEUTICAL COMAPNY·Filed 2005·Application pending·0 cites
- 3044US2009220435A1Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agentsNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 3140US2006040882A1Compostions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cellsCHEN LISHAN·Filed 2005·Application pending·0 cites
- 3239US2013072424A1Compounds and methods for peptide ribonucleic acid condensate particles for rna therapeuticsADAMI ROGER C·Filed 2012·Application pending·0 cites
- 3338US2006035815A1Pharmaceutical compositions for delivery of ribonucleic acid to a cellNASTECH PHARM CO·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kunyuan Cui files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →